Saturday, November 17, 2018 7:15:48 AM
In 2014, the Company issued an option to a noteholder to acquire 100,000 (split adjusted) shares at an exercise price of $0.20 per share with an expiration date of September 19, 2019. In 2016, the Company issued three warrants to an equity investor to purchase an aggregate 1,275,000 (split adjusted) shares at an exercise price of $0.20 per share with expiration dates ranging from August 18, 2020 to December 5, 2020 and an option to the Company’s Chief Executive Officer to purchase 2,000,000 (split adjusted) shares at an exercise price of 0.10 per share with an expiration date of December 31, 2026. In the first quarter of 2017, the Company issued an option to a consultant to acquire 1,000,000 (split adjusted) shares at an exercise price of $0.20 per share with an expiration date of March 19, 2019. On May 30, 2017, the Company issued warrants to a private investor to acquire up to 5,000 (split adjusted) shares of the Company’s common stock at a price of $2.50 per share.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM